Cellular Dynamics raises $40.6mm in Series B money; closes round at $73.1mm
Executive Summary
Cellular Dynamics International (creating stem cell therapies from adult tissue) has raised $35.6mm through its Series B round. Seven investors participated, including returning shareholders Tactics II Stem Cell Ventures and the Wisconsin Alumni Research Foundation, and new investor Sixth Floor Investors (which contributes a board member). CDI has brought in about $70mm since it was formed in 2004; its $30mm Series A round closed last year with funds from Tactics II and WARF.
Deal Industry
- Pharmaceuticals
- Services
-
Biotechnology
-
Drug Discovery Tools
- ADMET
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice